Caroline Peeples, NP
Women's Health · Flowood, MSNPI 1598328684
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations.
Across 99 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$268
- Astellas Pharma US Inc$164
- Exeltis, USA Inc.$162
- Hologic Sales And Service, LLC$146
- Organon$135
- Pfizer$123
- plus $725 from 15 others
What the payments were for
- Food & beverage$1,63095%
- Education$945%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $268 |
| Astellas Pharma US Inc | 8 | $164 |
| Exeltis, USA Inc. | 9 | $162 |
| Hologic Sales And Service, LLC | 8 | $146 |
| Organon | 9 | $135 |
| Pfizer | 7 | $123 |
| Mayne Pharma Commercial LLC | 7 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $110 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $103 |
| Novo Nordisk | 6 | $102 |
| Lilly USA, LLC | 4 | $62 |
| Shield Therapeutics Inc | 2 | $39 |
| Bayer | 2 | $37 |
| Avion Pharmaceuticals | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Exact Sciences | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Merck | 1 | $11 |
How this compares
$1,724 in reported general payments places this provider in the 80th percentile of 66 women's health providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $690 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $299 |
| Fluconazole | 14 | $105 |
Paid to pharmacies, not to this prescriber.
Other women's health in Flowood
- Courtney MathisFlowood$2K
- Rebecca BatesFlowood$2K
- Jordan BlockerFlowood$1K
- Lakendria ZollicofferFlowood$649
- Lauren WootenFlowood$503
- Casey HargettTupelo$7K
- Kathryn ElliottOxford$7K
- Jennifer FredricksonSouthaven$6K
- Wanda BrownOlive Branch$4K
- Deborah VerucchiSouthaven$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.